BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14651590)

  • 1. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery.
    Da'dara AA; Skelly PJ; Fatakdawala M; Visovatti S; Eriksson E; Harn DA
    Parasite Immunol; 2002 Apr; 24(4):179-87. PubMed ID: 12010483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice.
    Da'dara AA; Skelly PJ; Wang MM; Harn DA
    Vaccine; 2001 Nov; 20(3-4):359-69. PubMed ID: 11672898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
    Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.
    Ganley-Leal LM; Guarner J; Todd CW; Da'Dara AA; Freeman GL; Boyer AE; Harn DA; Secor WE
    Parasite Immunol; 2005 Sep; 27(9):341-9. PubMed ID: 16149992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective efficacy induced by different heterologous prime-boost strategies encoding triosephosphate isomerase against Schistosoma japonicum in mice.
    Dai Y; Zhao S; Tang J; Xing Y; Qu G; Dai J; Jin X; Wang X
    Parasit Vectors; 2017 Feb; 10(1):111. PubMed ID: 28241779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
    PacĂ­fico LG; Fonseca CT; Chiari L; Oliveira SC
    Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
    Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
    Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
    Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P
    Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
    J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
    Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
    Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).
    Zhang W; Ahmad G; Torben W; Siddiqui AA
    Acta Trop; 2011 May; 118(2):142-51. PubMed ID: 21334302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica.
    Dai Y; Zhu Y; Harn DA; Wang X; Tang J; Zhao S; Lu F; Guan X
    Clin Vaccine Immunol; 2009 Dec; 16(12):1796-803. PubMed ID: 19812258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
    Ahmad G; Zhang W; Torben W; Ahrorov A; Damian RT; Wolf RF; White GL; Carey DW; Mwinzi PN; Ganley-Leal L; Kennedy RC; Siddiqui AA
    J Infect Dis; 2011 Nov; 204(9):1437-49. PubMed ID: 21921206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine.
    Romeih MH; Hassan HM; Shousha TS; Saber MA
    Acta Biochim Biophys Sin (Shanghai); 2008 Apr; 40(4):327-38. PubMed ID: 18401531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine.
    Guo YJ; Sun SH; Zhang Y; Chen ZH; Wang KY; Huang L; Zhang S; Zhang HY; Wang QM; Wu D; Zhu WJ
    Vaccine; 2004 Sep; 22(29-30):3841-7. PubMed ID: 15364430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica].
    Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.